Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia S Nunes

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|December 19, 2019
Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving UnderstandingNatalia S Nunes, Christopher G Kanakry
Brain, Behavior, & Immunity - Health|January 3, 2022
Cholinergic immunomodulation in inflammatory bowel diseasesMichele A Serafini, Ana H Paz, Natalia S Nunes
Theranostics|March 17, 2025
Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteinsJin Kyeong Choi, Evaristus C Mbanefo, Manoj Kumar Yadav, et al.
Frontiers in Immunology|March 4, 2022
Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4<sup>+</sup> T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell TransplantationAshley D Hadjis, Natalia S Nunes, Shanzay M Khan, et al.
Blood Advances|July 12, 2022
Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamideMichael T Patterson, Natalia S Nunes, Lucas P Wachsmuth, et al.
Transplantation and Cellular Therapy|July 5, 2025
REMOVED: Post-Transplantation Cyclophosphamide Protects the Thymus from Alloreactive T-Cell Damage after T-Cell-Replete MHC-Haploidentical Hematopoietic Cell Transplantation but Does Not Rescue Normal Medullary Thymic Epithelial Cell Differentiation or Intrathymic Clonal DeletionAlessandra De Paula Pohl, Marie Pouzolles, Tsion Mekonmen, et al.
Experimental Hematology|August 5, 2018
Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemiaCamilla de S Borges, Aline F Ferreira, Vitor H Almeida, et al.
Blood Advances|January 3, 2023
Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences TregsRochelle E Fletcher, Natalia S Nunes, Michael T Patterson, et al.
Blood|October 6, 2022
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effectsMichael T Patterson, Shanzay M Khan, Natalia S Nunes, et al.
Nature Communications|April 23, 2026
Allogeneic hematopoietic cell transplantation in mature T- or NK-lymphomas: a phase II clinical trialKamil A Rechache, Natalia S Nunes, Jennifer Sponaugle, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|December 19, 2019
Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving UnderstandingNatalia S Nunes, Christopher G Kanakry
Brain, Behavior, & Immunity - Health|January 3, 2022
Cholinergic immunomodulation in inflammatory bowel diseasesMichele A Serafini, Ana H Paz, Natalia S Nunes
Theranostics|March 17, 2025
Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteinsJin Kyeong Choi, Evaristus C Mbanefo, Manoj Kumar Yadav, et al.
Frontiers in Immunology|March 4, 2022
Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4<sup>+</sup> T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell TransplantationAshley D Hadjis, Natalia S Nunes, Shanzay M Khan, et al.
Blood Advances|July 12, 2022
Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamideMichael T Patterson, Natalia S Nunes, Lucas P Wachsmuth, et al.
Transplantation and Cellular Therapy|July 5, 2025
REMOVED: Post-Transplantation Cyclophosphamide Protects the Thymus from Alloreactive T-Cell Damage after T-Cell-Replete MHC-Haploidentical Hematopoietic Cell Transplantation but Does Not Rescue Normal Medullary Thymic Epithelial Cell Differentiation or Intrathymic Clonal DeletionAlessandra De Paula Pohl, Marie Pouzolles, Tsion Mekonmen, et al.
Experimental Hematology|August 5, 2018
Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemiaCamilla de S Borges, Aline F Ferreira, Vitor H Almeida, et al.
Blood Advances|January 3, 2023
Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences TregsRochelle E Fletcher, Natalia S Nunes, Michael T Patterson, et al.
Blood|October 6, 2022
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effectsMichael T Patterson, Shanzay M Khan, Natalia S Nunes, et al.
Nature Communications|April 23, 2026
Allogeneic hematopoietic cell transplantation in mature T- or NK-lymphomas: a phase II clinical trialKamil A Rechache, Natalia S Nunes, Jennifer Sponaugle, et al.
Pageof 2